US HR2296

Bill

More Efficient Tools to Realize Information for Consumers Act

Introduced
04/12/2019

In Committee
07/17/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A BILL To require reporting regarding certain drug price increases, and for other purposes. HR 2296 RH 1

AI Summary

This bill, the More Efficient Tools to Realize Information for Consumers (METRIC) Act, requires pharmaceutical manufacturers to report information on certain drug price increases of 10% or more within a single calendar year or 25% or more within three consecutive calendar years. The bill also makes drug discount information reported by pharmacy benefit managers (PBMs) publicly available, and requires PBM real-time benefit tools to provide information to prescribers on formulary status, cost-sharing, and clinically appropriate alternatives for prescription drugs. Additionally, the bill directs the Federal Trade Commission to study the pharmaceutical supply chain, including the role of PBMs and pharmacy services administrative organizations, and their impact on competition and consumer costs.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (9)

Jan Schakowsky (D)*, Buddy Carter (R), Lloyd Doggett (D), Morgan Griffith (R), Mark Pocan (D), Francis Rooney (R), John Sarbanes (D), Tom Suozzi (D), Lauren Underwood (D),

Last Action

Placed on the Union Calendar, Calendar No. 170. (on 09/24/2019)

Official Document

https://www.congress.gov/bill/116th-congress/house-bill/2296/all-info

(13 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://www.congress.gov/bill/116th-congress/house-bill/2296/all-info
BillText	https://www.congress.gov/116/bills/hr2296/BILLS-116hr2296rh.pdf
Bill	https://www.congress.gov/116/bills/hr2296/BILLS-116hr2296rh.pdf.pdf
BillText	https://www.congress.gov/116/bills/hr2296/BILLS-116hr2296ih.pdf
Bill	https://www.congress.gov/116/bills/hr2296/BILLS-116hr2296ih.pdf.pdf

Bill	Bill Name	Last Action	Type
HR19	Lower Costs, More Cures Act of 2019	Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.	Related
HR2087	Drug Price Transparency Act	Subcommittee Hearings Held.	Related
HR2115	Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act	Received in the Senate and Read twice and referred to the Committee on Finance.	Related
HR2376	Prescription Pricing for the People Act of 2019	Subcommittee Hearings Held.	Related
HR2452	Medicare for America Act of 2019	Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.	Related
HR3	Elijah E. Cummings Lower Drug Costs Now Act	Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.	Related
HR3408	Shop Rx Act of 2019	Referred to the Subcommittee on Health.	Related
HR3415	Real-Time Beneficiary Drug Cost Bill	Referred to the Subcommittee on Health.	Related
HR7898	To amend title XXX of the Public Health Services Act to provide for a technical correction to provide the Inspector General of the Department of Health and Human Service certain authorities with respect to investigations of information blocking, and for other purposes.	Became Public Law No: 116-321.	Related
S1227	Prescription Pricing for the People Act of 2019	Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.	Related
S1391	Fair Accountability and Innovative Research Drug Pricing Act of 2019	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.	Related
S1895	Lower Health Care Costs Act	Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.	Related
S2051	Strengthening Average Sales Price Reporting Act of 2019	Read twice and referred to the Committee on Finance.	Related

Bill > HR2296

US HR2296

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (9)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary